BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 24672577)

  • 1. Adverse Drug Reactions and Expected Effects to Therapy with Subcutaneous Mistletoe Extracts (Viscum album L.) in Cancer Patients.
    Steele ML; Axtner J; Happe A; Kröz M; Matthes H; Schad F
    Evid Based Complement Alternat Med; 2014; 2014():724258. PubMed ID: 24672577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use and safety of intratumoral application of European mistletoe (Viscum album L) preparations in Oncology.
    Steele ML; Axtner J; Happe A; Kröz M; Matthes H; Schad F
    Integr Cancer Ther; 2015 Mar; 14(2):140-8. PubMed ID: 25552476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune-related and adverse drug reactions to low versus high initial doses of Viscum album L. in cancer patients.
    Schad F; Thronicke A; Merkle A; Matthes H; Steele ML
    Phytomedicine; 2017 Dec; 36():54-58. PubMed ID: 29157828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficacy and safety of long-term complementary treatment with standardized European mistletoe extract (Viscum album L.) in addition to the conventional adjuvant oncologic therapy in patients with primary non-metastasized mammary carcinoma. Results of a multi-center, comparative, epidemiological cohort study in Germany and Switzerland].
    Bock PR; Friedel WE; Hanisch J; Karasmann M; Schneider B
    Arzneimittelforschung; 2004; 54(8):456-66. PubMed ID: 15460213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of Intravenous Application of Mistletoe (Viscum album L.) Preparations in Oncology: An Observational Study.
    Steele ML; Axtner J; Happe A; Kröz M; Matthes H; Schad F
    Evid Based Complement Alternat Med; 2014; 2014():236310. PubMed ID: 24955100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of the long-term adjuvant treatment of primary intermediate- to high-risk malignant melanoma (UICC/AJCC stage II and III) with a standardized fermented European mistletoe (Viscum album L.) extract. Results from a multicenter, comparative, epidemiological cohort study in Germany and Switzerland.
    Augustin M; Bock PR; Hanisch J; Karasmann M; Schneider B
    Arzneimittelforschung; 2005; 55(1):38-49. PubMed ID: 15727163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrolective, comparative, epidemiological cohort study with parallel groups design for evaluation of efficacy and safety of drugs with "well-established use".
    Bock PR; Friedel WE; Hanisch J; Karasmann M; Schneider B
    Forsch Komplementarmed Klass Naturheilkd; 2004 Aug; 11 Suppl 1():23-9. PubMed ID: 15353899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remedies containing Asteraceae extracts: a prospective observational study of prescribing patterns and adverse drug reactions in German primary care.
    Jeschke E; Ostermann T; Lüke C; Tabali M; Kröz M; Bockelbrink A; Witt CM; Willich SN; Matthes H
    Drug Saf; 2009; 32(8):691-706. PubMed ID: 19591533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fever Therapy With Intravenously Applied Mistletoe Extracts for Cancer Patients: A Retrospective Study.
    Schläppi M; Ewald C; Kuehn JJ; Weinert T; Huber R
    Integr Cancer Ther; 2017 Dec; 16(4):479-484. PubMed ID: 27387685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of intravenously applied mistletoe extract - results from a phase I dose escalation study in patients with advanced cancer.
    Huber R; Schlodder D; Effertz C; Rieger S; Tröger W
    BMC Complement Altern Med; 2017 Sep; 17(1):465. PubMed ID: 28923036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use and safety of anthroposophic medications in chronic disease: a 2-year prospective analysis.
    Hamre HJ; Witt CM; Glockmann A; Tröger W; Willich SN; Kiene H
    Drug Saf; 2006; 29(12):1173-89. PubMed ID: 17147463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristics and therapeutic behavior of breast cancer patients using mistletoe therapy consulting a clinic offering integrative oncology: a registry data analysis.
    Krüerke D; Schenker M; Matter-Walstra K
    BMC Complement Med Ther; 2023 Nov; 23(1):395. PubMed ID: 37924102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complementary Treatment with Mistletoe Extracts During Chemotherapy: Safety, Neutropenia, Fever, and Quality of Life Assessed in a Randomized Study.
    Pelzer F; Tröger W; Nat DR
    J Altern Complement Med; 2018; 24(9-10):954-961. PubMed ID: 30247950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study on local inflammatory reactions and other parameters during subcutaneous mistletoe application in HIV-positive patients and HIV-negative subjects over a period of 18 weeks.
    Stoss M; van Wely M; Musielsky H; Gorter RW
    Arzneimittelforschung; 1999 Apr; 49(4):366-73. PubMed ID: 10337457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical safety of combined therapy of immune checkpoint inhibitors and Viscum album L. therapy in patients with advanced or metastatic cancer.
    Thronicke A; Steele ML; Grah C; Matthes B; Schad F
    BMC Complement Altern Med; 2017 Dec; 17(1):534. PubMed ID: 29237435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of mistletoe preparations (Viscum album) for patients with cancer diseases. A systematic review.
    Melzer J; Iten F; Hostanska K; Saller R
    Forsch Komplementmed; 2009 Aug; 16(4):217-26. PubMed ID: 19729932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Additional treatment with mistletoe extracts for patients with breast cancer compared to conventional cancer therapy alone - efficacy and safety, costs and cost-effectiveness, patients and social aspects, and ethical assessment.
    Schnell-Inderst P; Steigenberger C; Mertz M; Otto I; Flatscher-Thöni M; Siebert U
    Ger Med Sci; 2022; 20():Doc10. PubMed ID: 36160875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic evaluation of the clinical effects of supportive mistletoe treatment within chemo- and/or radiotherapy protocols and long-term mistletoe application in nonmetastatic colorectal carcinoma: multicenter, controlled, observational cohort study.
    Friedel WE; Matthes H; Bock PR; Zänker KS
    J Soc Integr Oncol; 2009; 7(4):137-45. PubMed ID: 19883529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective controlled cohort studies on long-term therapy of ovairian cancer patients with mistletoe (Viscum album L.) extracts iscador.
    Grossarth-Maticek R; Ziegler R
    Arzneimittelforschung; 2007; 57(10):665-78. PubMed ID: 18074761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phytochemical analysis and in vitro anti-proliferative activity of Viscum album ethanolic extracts.
    Holandino C; Melo MNO; Oliveira AP; Batista JVDC; Capella MAM; Garrett R; Grazi M; Ramm H; Torre CD; Schaller G; Urech K; Weissenstein U; Baumgartner S
    BMC Complement Med Ther; 2020 Jul; 20(1):215. PubMed ID: 32646417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.